← Back to Patent Explorer
US4687760A Expired / Lapsed US ⏱️ 0.0 years remaining

Reduced peptides which inhibit gastric secretion, process for their preparation and pharmaceutical compositions in which they are present

Assignee: Sanofi SA
•
Filing: 1985-12-16
•
Granted: 1987-08-18
•
Expires: 2005-12-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to the peptides of the formula: <IMAGE> (I) <IMAGE> in which: R1 represents hydrogen or a protecting group for the amine group, such as t-butoxycarbonyl, benzyloxycarbonyl or lower alkanoyl groups; X represents beta-alanine glycine or a direct bond between R1 and the amine group; and R2 represents a group chosen from: <IMAGE> corresponding to the side chains of the natural amino acid leucine, methionine and norleucine. These peptides inhibit gastric secretion.

Inventors

  • 👤 Jean Martinez
  • 👤 Jean-Pierre Bali
  • 👤 Richard Magous
  • 👤 Bertrand Castro
  • 👤 Henri Demarne

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 11:50
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06104; C07K5/06113; A; A61; A61P; A61P1/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 70 words
A peptide corresponding to the general formula: ##STR26## in which: R 1 represents hydrogen or a protecting group for the amine group; benzyloxycarbonyl X represents beta-alanine, glycine or a direct bond between R 1 and the amine group; and R 2 represents a group chosen from: ##STR27## corresponding to the side chains of the natural amino acids leucine, methionine and norleucine, and also its salts with inorganic or organic bases.
Claim 2
Dependent Claim 70 words
A peptide corresponding to the general formula: ##STR26## in which: R 1 represents hydrogen or a protecting group for the amine group; benzyloxycarbonyl X represents beta-alanine, glycine or a direct bond between R 1 and the amine group; and R 2 represents a group chosen from: ##STR27## corresponding to the side chains of the natural amino acids leucine, methionine and norleucine, and also its salts with inorganic or organic bases.
Claim 3
Dependent Claim 25 words
A peptide as claimed in claim 1, which corresponds to the formula: ##STR28## in which R 2 has the same meaning mentioned in claim 1.
Claim 4
Dependent Claim 16 words
A peptide as claimed in claim 1, wherein X is glycine and R 2 is leucine.
Claim 5
Dependent Claim 10 words
A peptide as claimed in claim 1 which is: ##STR29##
Claim 6
Dependent Claim 10 words
A peptide as claimed in claim 1 which is: ##STR30##
Claim 7
Dependent Claim 10 words
A peptide as claimed in claim 1 which is: ##STR31##
Claim 8
Dependent Claim 10 words
A peptide as claimed in claim 1 which is: ##STR32##
Claim 9
Dependent Claim 21 words
A peptide as claimed in claim 1 wherein R 1 is a protecting group which is t-butoxycarbonyl, benzyloxycarbonyl or lower alkanoyl.
Claim 10
Dependent Claim 34 words
A pharmaceutical composition for inhibiting gastric secretion which contains, as active ingredient, an effective amount for inhibiting gastric secretion of a peptide as claimed in claim 1 in association with a pharmaceutically acceptable vehicle.
Claim 11
Dependent Claim 34 words
A pharmaceutical composition for inhibiting gastric secretion which contains, as active ingredient, an effective amount for inhibiting gastric secretion of a peptide as claimed in claim 2 in association with a pharmaceutically acceptable vehicle.
Claim 12
Dependent Claim 34 words
A pharmaceutical composition for inhibiting gastric secretion which contains, as active ingredient, an effective amount for inhibiting gastric secretion of a peptide as claimed in claim 3 in association with a pharmaceutically acceptable vehicle.

References Cited (Backward Citations)

GB1042481A Cited
EP0012401A1 Cited
FR2533210A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-08-17 1991-02-16 1991-08-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-08-17 1995-02-16 1995-08-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-08-17 1999-02-16 1999-08-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag